Oversea-Chinese Banking Corp (OCBC)’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-2,803
Closed -$400K – 442
2024
Q2
$400K Sell
2,803
-2,072
-43% -$319K 0.01% 298
2024
Q1
$761K Sell
4,875
-2,537
-34% -$409K 0.02% 249
2023
Q4
$1.34M Sell
7,412
-2,222
-23% -$402K 0.05% 171
2023
Q3
$1.73M Buy
9,634
+4,457
+86% +$882K 0.08% 156
2023
Q2
$922K Sell
5,177
-56
-1% -$12.9K 0.04% 186
2023
Q1
$1.13M Buy
5,233
+3,971
+315% +$953K 0.06% 171
2022
Q4
$278K Buy
+1,262
New +$231K 0.02% 300

Other funds holding ONC

Oversea-Chinese Banking Corp (OCBC)'s ONC Position: Q3 2024 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of BeOne Medicines Ltd (ONC) in Q3 2024, closing a stake of 2,803 shares — an estimated $400K sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in ONC in Q4 2022 and held it in 7 quarters. The position peaked at $1.73M in Q3 2023. 228 funds tracked by Wall St. Rank hold ONC as of Q3 2024.

  • Oversea-Chinese Banking Corp (OCBC) reported no remaining BeOne Medicines Ltd position as of Q3 2024 after selling out during the quarter.
  • Oversea-Chinese Banking Corp (OCBC) sold 2,803 BeOne Medicines Ltd shares in Q3 2024, an estimated $400K.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in BeOne Medicines Ltd in Q4 2022 and held it in 7 quarters.
  • Oversea-Chinese Banking Corp (OCBC)'s BeOne Medicines Ltd position peaked at $1.73M in Q3 2023.
  • 228 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2024.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q3 2024, filed 5 Nov 2024.